PROTEAN logo

Protean eGov Technologies Limited IPO

ListedMainboard
Price band
₹752 – ₹792
Open – close
06 Nov 2023
to 08 Nov 2023
Listing
06 Feb 2025

What the filing actually says

Our read of the offer document and the exchange data — not the issuer's summary of itself

We can't judge this issue yet. A verdict needs at least three independent dimensions — valuation, growth, profitability, balance sheet, issue structure, governance or demand — and this issue does not yet publish enough of them for a read that would mean anything. No offer document for this issue has been published yet. A confident score from two fields would be worse than this notice.

Dates

The issuer's tentative timetable — a date passing is not confirmation the step completed

  1. Opens
    06 Nov 2023
  2. Closes
    08 Nov 2023
  3. Listing
    06 Feb 2025

The offering

Terms, structure and who is selling

Terms
Price band₹752 – ₹792
Listing atMainboard
Company & valuation
ISININE004A01022

What happened to comparable issues

The last 8 issues to list with a recorded opening price, most comparable first

Median listing gain
+6.7%
Listed up
6 of 8
Best
+47.2%
SS Retail Limited
Worst
-2.4%
Hero Motors Limited
NSEsame segment
5.7× sub+0.8%
2.0× sub+3.3%
177.0× sub+29.0%
SS Retail Limitedsame segment
107.4× sub+47.2%
7.0× sub-2.4%
29.5× sub+0.0%
14.6× sub+10.0%
66.0× sub+26.0%

Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.

Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.

Protean eGov Technologies Limited IPO — GMP, subscription & review | DocStoX